Global In Vitro Diagnostics Market
The Global In Vitro Diagnostics (IVD) Market size is estimated to be USD 98.2 billion in 2022 and is projected to reach USD 113.1 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 2.9% during the forecast period, 2022 – 2027.
The Global In Vitro Diagnostics market delivers a comprehensive evaluation of the market. It does give a comprehensive analysis via research study which observes historical data & emerging technology to determine the industry’s growth drivers.
The growth of the In Vitro Diagnostics (IVD) market is driven by the rising geriatric population, the subsequent growth in the prevalence of chronic and infectious diseases, rising adoption of fully automated and POC instruments in developed regions, increasing awareness regarding diseases diagnosis in developing regions, and growing R&D investments by industry vendors to launch new IVD products.
In this report study, the key trend prospects & important drivers for the In Vitro Diagnostics market’s growth are explored and analysed in depth. The market dynamics included in the report includes drivers, restraints, opportunities, and challenges, which may have a positive or negative impact on market overall growth.
Global In Vitro Diagnostics Market Report Objective
This report helps the user understand the market in terms of definition, segmentation, market potential, key trends, and industry challenges. Industry analysis was undertaken across the report’s framework, which will help readers obtain a comprehensive scenario of the market. The market statistics & data were acquired from reliable sources such as websites, annual reports of companies, journals, and other publications, then double-checked and validated by industry experts.
This report also covers PORTER’S five forces to help determine several factors like the threat of substitutes, competitive analysis, power of buyer, supplier as well as the threat of new entry. The report has classified the Global In Vitro Diagnostics Market based on Product and Service, Test Type, Technology, Application, End User, and Region.
Key Players:
The Global In Vitro Diagnostics Market is dominated by major players such as QIAGEN N.V, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Abbott, Thermo Fisher Scientific, Agilent Technologies, Inc., Johnson & Johnson, Becton, Dickinson and Company, Bio-Rad Laboratories, Sysmex Corporation, bioMérieux, DiaSorin, Ortho Clinical Diagnostics, Charles River Laboratories etc.
Market Taxonomy
By Product and Service
By Technology
By Application
By End User
By Region
Global In Vitro Diagnostics Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global In Vitro Diagnostics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global In Vitro Diagnostics Market, By Product and Service
5.1 Y-o-Y Growth Comparison, By Product and Service
5.2 Global In Vitro Diagnostics Market Share Analysis, By Product and Service
5.3 Global In Vitro Diagnostics Market Size and Forecast, By Product and Service
5.3.1 Reagents & Kits
5.3.2 Instruments
5.3.3 Services
5.3.4 Data Management Software
6 Global In Vitro Diagnostics Market, By Test Type
6.1 Y-o-Y Growth Comparison, By Test Type
6.2 Global In Vitro Diagnostics Market Share Analysis, By Test Type
6.3 Global In Vitro Diagnostics Market Size and Forecast, By Test Type
6.3.1 Clinical Chemistry
6.3.2 Molecular Diagnostics
6.3.3 Immuno Diagnostics
6.3.4 Hematology
7 Global In Vitro Diagnostics Market, By Technology
7.1 Y-o-Y Growth Comparison, By Technology
7.2 Global In Vitro Diagnostics Market Share Analysis, By Technology
7.3 Global In Vitro Diagnostics Market Size and Forecast, By Technology
7.3.1 Diesel Locomotive
7.3.2 Reagents & Kits
7.3.3 Instruments
7.3.4 Services
7.3.5 Data Management Software
7.3.6 Others
8 Global In Vitro Diagnostics Market, By Application
8.1 Y-o-Y Growth Comparison, By Application
8.2 Global In Vitro Diagnostics Market Share Analysis, By Application
8.3 Global In Vitro Diagnostics Market Size and Forecast, By Application
8.3.1 Reagents & Kits
8.3.2 Instruments
8.3.3 Services
8.3.4 Data Management Software
9 Global In Vitro Diagnostics Market, By End User
9.1 Y-o-Y Growth Comparison, By End User
9.2 Global In Vitro Diagnostics Market Share Analysis, By End User
9.3 Global In Vitro Diagnostics Market Size and Forecast, By End User
9.3.1 Hospital laboratories
9.3.2 Clinical laboratories
9.3.3 Point-of-care testing centers
9.3.4 Academic institutes
9.3.5 Patients
9.3.6 Other
10 Global In Vitro Diagnostics Market, By Region
10.1 Global In Vitro Diagnostics Market Share Analysis, By Region
10.2 Global In Vitro Diagnostics Market Share Analysis, By Region
10.3 Global In Vitro Diagnostics Market Size and Forecast, By Region
11 North America In Vitro Diagnostics Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 North America In Vitro Diagnostics Market Share Analysis, By Product and Service
11.3 North America In Vitro Diagnostics Market Size and Forecast, By Test Type
11.4 North America In Vitro Diagnostics Market Size and Forecast, By Technology
11.5 North America In Vitro Diagnostics Market Size and Forecast, By Application
11.6 North America In Vitro Diagnostics Market Size and Forecast, By End User
11.7 North America In Vitro Diagnostics Market Size and Forecast, By Country
11.7.1 U.S.
11.7.2 Canada
11.7.3 Mexico
12 Europe In Vitro Diagnostics Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Europe In Vitro Diagnostics Market Share Analysis, By Product and Service
12.3 Europe In Vitro Diagnostics Market Size and Forecast, By Test Type
12.4 Europe In Vitro Diagnostics Market Size and Forecast, By Technology
12.5 Europe In Vitro Diagnostics Market Size and Forecast, By Application
12.5 Europe In Vitro Diagnostics Market Size and Forecast, By End User
12.7 Europe In Vitro Diagnostics Market Size and Forecast, By Country
12.7.1 Germany
12.7.2 France
12.7.3 UK
12.7.4 Rest of Europe
13 Asia Pacific In Vitro Diagnostics Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Asia Pacific In Vitro Diagnostics Market Share Analysis, By Product and Service
13.3 Asia Pacific In Vitro Diagnostics Market Size and Forecast, By Test Type
13.4 Asia Pacific In Vitro Diagnostics Market Size and Forecast, By Technology
13.5 Asia Pacific In Vitro Diagnostics Market Size and Forecast, By Application
13.6 Asia Pacific In Vitro Diagnostics Market Size and Forecast, By End User
13.7 Asia Pacific In Vitro Diagnostics Market Size and Forecast, By Country
13.7.1 China
13.7.2 Japan
13.7.3 India
13.7.4 Rest of Asia Pacific
14 Latin America In Vitro Diagnostics Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Latin America In Vitro Diagnostics Market Share Analysis, By Product and Service
14.3 Latin America In Vitro Diagnostics Market Size and Forecast, By Test Type
14.4 Latin America In Vitro Diagnostics Market Size and Forecast, By Technology
14.5 Latin America In Vitro Diagnostics Market Size and Forecast, By Application
14.6 Latin America In Vitro Diagnostics Market Size and Forecast, By End User
14.7 Latin America In Vitro Diagnostics Market Size and Forecast, Country
14.7.1 Brazil
14.7.2 Rest of Latin America
15 Middle East In Vitro Diagnostics Market Analysis and Forecast (2022-2027)
15.1 Introduction
15.2 Middle East In Vitro Diagnostics Market Share Analysis, By Product and Service
15.3 Middle East In Vitro Diagnostics Market Size and Forecast, By Test Type
15.4 Middle East In Vitro Diagnostics Market Size and Forecast, By Technology
15.5 Middle East In Vitro Diagnostics Market Size and Forecast, By Application
15.6 Middle East In Vitro Diagnostics Market Size and Forecast, By End User
15.7 Middle East In Vitro Diagnostics Market Size and Forecast, By Country
15.7.1 Saudi Arabia
15.7.2 UAE
15.7.3 Egypt
15.7.4 Kuwait
15.7.5 South Africa
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1 QIAGEN N.V
17.1.1 Overview
17.1.2 Offerings
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2 Roche Diagnostics
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3 Siemens Healthineers
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 Danaher Corporation
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
16.4.6 Key Strategies
17.5 Abbott
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 Thermo Fisher Scientific
16.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 Agilent Technologies, Inc.
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8 bioMérieux
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 Becton, Dickinson and Company
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10 Bio-Rad Laboratories
17.10.1 Overview
17.10.2 Offerings
17.10.3 Key Financials
17.10.4 Business Segment & Geographic Overview
17.10.5 Key Market Developments
17.10.6 Key Strategies
